Recommended as Stock of the Week on March 9, 2026

Fortive: The silent precision maker that hardly anyone knows - but many need

TickerFTV.NYSE
Recommended Price55.66 USD
Current Price 55.66 USD
Fortive Corp – stock chart

Scores at time of recommendation (March 9, 2026)

Leeway Score
60/100
Excellent
Business Rating
72/100
Excellent
Market-Fit Rating
58/100
Fair
Cycle Rating
52/100
Fair

More about our scores in Help

5-year stock timeline

2021-07-12 Fortive announced a definitive agreement to acquire ServiceChannel for approximately $1.2 billion, expected to close in Q3 2021. ServiceChannel was projected to contribute roughly $125M in revenue for 2021 and enhance Fortive's recurring-revenue profile and guidance. [1]

The market began viewing Fortive as accelerating its shift into SaaS and recurring-revenue businesses, moving away from pure industrial operations toward software-enabled workflows. [1]

The stock moved from an earlier uptrend into consolidation as investors absorbed the strategic shift. [2]

2021-12-27 Fortive completed its acquisition of Provation, a healthcare workflow software company. Shortly after, the company reported Q4 and full-year 2021 results showing approximately 10% core revenue growth and EPS expansion. [3][4]

The Provation close reinforced the thesis that Fortive was building recurring-revenue software scale within its Advanced Healthcare Solutions portfolio. Investors increasingly framed Fortive as a hybrid industrial-plus-software compounder. [4]

Price action showed a constructive trend into early 2022, with periodic rallies on execution beats as operational results and software M&A supported multiple expansion. [4]

2023-10-23 Fortive announced an agreement to acquire EA Elektro-Automatik, an electronic test and measurement company serving energy storage, EV, and hydrogen markets, for approximately $1.45 billion with expected close in early Q1 2024. [6][7]

The market positioned this as strategic for capturing energy-transition end markets and potentially accretive to margins within the Precision Technologies portfolio. M&A was seen as essential to sustaining growth and tech exposure. [6]

M&A headlines triggered sharp upticks, though the stock largely remained in a multi-month range as broader industrial and tech cyclicality weighed on momentum. [6]

2024-01-03 Fortive closed the EA Elektro-Automatik acquisition with details disclosed in SEC filings regarding total consideration, goodwill, and financing. [8]

The close removed execution uncertainty and reinforced management's message of portfolio shaping, adding high-power test assets tied to secular growth drivers. Investor focus shifted toward integration and near-term financing. [8]

Brief volatility surrounded the financing and close, followed by resumed upward bias as investors incorporated the acquisition into forward estimates.

2024-01-31 Fortive reported Q4 and full-year 2023 results with FY2023 revenue of approximately $6.07B, messaging improved through-cycle consistency and Fortive Business System-driven margin progress. [5]

The company's messaging of predictable mid-single-digit core growth, mid-teens EPS and free cash flow compounding, and structural margin expansion via FBS strengthened the "quality compounder" perception. [5]

An earnings-driven rally rewarded margin expansion and consistent cash generation.

2024-04-24 Fortive reported Q1 2024 results: total revenue +4% (core +3%), record gross and operating margins, and raised full-year outlook for adjusted EPS and free cash flow. [9][10]

Results reinforced the view that FBS execution was delivering double-digit EPS and free cash flow compounding despite modest top-line growth. The narrative shifted toward a premium multiple reflecting margin resiliency and cash return capacity. [9]

A confirmation breakout followed as guidance was raised and results beat expectations.

2024 (reported 2025) Full-year 2024 summary showed modest revenue growth, adjusted operating margin expansion to a record of approximately 26.9%, strong free cash flow, and approximately $1.0B returned to shareholders through roughly 12M shares repurchased. [11]

Fortive was increasingly characterized as a cash-compounding, capital-allocating business. Investor emphasis shifted toward margin and buyback execution even as core revenue growth moderated. [11]

Medium-term uptrend was punctuated by rangebound trading as markets weighed growth against margin and capital return.

2024-09-04 Management announced the intention for James A. Lico to retire upon completion of the planned spin-off of the Precision Technologies segment, targeted for Q4 2025. [12]

The market began pricing in corporate-action complexity and leadership transition risk, alongside the possibility of value unlocking through a targeted separation. [12]

Volatility and consolidation entered the announced corporate-action period with sideways trading and spikes on corporate-action updates.

2025-05-27 Fortive declared a pro-rata dividend of 100% of Ralliant common stock to Fortive shareholders, with record date June 16, 2025 and distribution June 28, 2025. When-issued trading was expected June 25, with regular trading resuming June 30. [15]

Formal timing for the spin-off crystallized investor expectations around de-conglomeration and value unlocking. Fortive would emerge focused on Intelligent Operating Solutions and Advanced Healthcare Solutions. [15]

Pre-ex-date volatility reflected investor position adjustments ahead of the distribution and related tax and framing considerations.

2025-06-28 to 2025-06-30 The separation completed with Ralliant distributed to Fortive shareholders at a ratio of one Ralliant share per three Fortive shares. Ralliant began regular trading as RAL. Fortive appointed Olumide Soroye as President and CEO; James Lico retired and briefly served as senior advisor. Ralliant's results were treated as discontinued operations in Fortive reporting. [13][16][19]

After separation, investors re-modeled Fortive as a narrower, higher-margin, software-and-services-heavy company focused on IOS and AHS. The spin-off was framed as value-enhancing but introduced near-term execution and identity transition risk under new leadership. [13][16]

Immediate post-spin volatility and re-pricing established a new baseline. Typical short-term drawdown and rotation preceded consolidation as analysts re-estimated earnings and multiples.

2025-07-30 Fortive reported Q2 2025 results and began reporting Ralliant as discontinued operations following the distribution. Management provided post-separation outlook commentary for the retained company. [14]

Earnings season confirmed the accounting and operational reset. Investors focused on organic growth prospects of the retained IOS and AHS businesses and on capital-allocation capacity going forward. [14]

Rangebound trading continued as investors awaited execution cadence and the first full-period results from the refocused company.

2026-07-11 Fortive traded at 62.2.

By mid-2026, the public narrative centered on Fortive as a leaner, cash-generative operator with strong margin pedigree through FBS and a higher mix of recurring software and services in IOS and AHS. Growth was viewed as moderate but higher quality. Investors balanced margins and buybacks against top-line moderation and macro sensitivity. [9][11]

The chart phase was characterized by post-spin consolidation, trading in a multi-month range with episodic rallies on earnings and operational beats and occasional drawdowns on macro risk.

Key Points

From recommendation (March 9, 2026)

  • Q4 2025: Sales +4.6% to 1.12 billion USD, expectations exceeded by 2.7%
  • Adjusted EPS growth ~13% in the quarter, annual EPS guidance exceeded
  • Adjusted EBITDA growth ~8% in the quarter - solid operational execution
  • P/E ratio 31.6x at PEG of 0.98 - growth is not overpriced in the price
  • EPS estimates: USD 2.97 (2025e) → USD 3.18 (2026e) - moderate, steady growth
  • Gates Capital holds FTV as top 5 position with ~134.8m. USD exposure
  • Equity ratio solid at 55%, no balance sheet stress recognizable

Investment Thesis

From recommendation (March 9, 2026)

Fortive is not a glamor title - and that's exactly the point. The Group builds measurement technology, precision instruments and industrial software for customers who simply cannot afford to make mistakes. This creates high switching costs, stable margins and pricing power that is rare in the industry. Following the spin-off from Ralliant, Fortive is now more focused with two clear segments: Intelligent Operating Solutions and Advanced Healthcare Solutions. Q4 was further proof that the new structure is working. No hype, no moonshot - but a business model that delivers in difficult markets.

Key risks and downside factors

Fortive operates across test and measurement, industrial sensors and safety, connected worker and facilities software, and healthcare sterilization and clinical workflow. It faces competition from specialized instrumentation firms and larger industrial conglomerates, where the real battles are fought over product performance, software and services recurring revenue, and pricing power. The company carries three material constraints: supply chain and component cost swings that hit margins unpredictably, the weight of medical and data regulation in its healthcare division, and lingering post-spin financial, tax, and indemnity obligations that can tighten capital allocation and compress returns.

  • Intense competition across multiple segments—test and measurement, sensors, industrial software, and healthcare sterilization—creates persistent pressure on pricing, demands sustained R&D investment, and threatens market position.
  • Supply-chain and input-cost exposure—reliance on limited or sole sources for key components, swings in commodity and freight costs, and tariff or trade policy volatility that can disrupt production and compress margins.
  • Regulatory and product-compliance risk in healthcare and industrial safety stems from FDA/MDR/UKCA oversight, post-market reporting obligations, and privacy and anti-fraud frameworks (HIPAA, Anti-Kickback, False Claims Act). Violations can trigger recalls, regulatory fines, sales restrictions, and materially higher compliance costs. [8], [3], [21]
  • Post-separation financial risks include indemnities and contingent liabilities carried over from the Ralliant spin-off, tax exposures tied to the separation transaction itself, and leverage combined with interest-rate sensitivity that could constrain both liquidity and strategic flexibility.

Competitive landscape

Fortive operates as a focused industrial-technology and healthcare-workflow company, split between Intelligent Operating Solutions and Advanced Healthcare Solutions. It competes against large diversified industrials and specialist vendors in diagnostics, instruments, industrial automation, and electronic instrumentation. The business faces familiar headwinds: cyclical industrial demand, competitors willing to spend aggressively on R&D and pricing, execution risk as the portfolio reshapes through M&A, and the ongoing regulatory and cybersecurity complexity that comes with healthcare and connected products.

CompanyTicker
Danaher CorporationDHR.NYSE
Emerson Electric Co.EMR.NYSE
AMETEK, Inc.AME.NYSE

Private competitors

  • Epic Systems
  • Censis
  • Surgical Information Systems (SIS)
  • iOFFICE

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Catalysts

From recommendation (March 9, 2026)

  • 17. March: CFO appearance on J.P. Morgan Industrials Conference - Guidance and capital allocation signals
  • Next quarterly results: Confirmation of margin path after Group reorganization
  • M&A-Updates: Fortive has recently completed acquisitions - further portfolio measures possible
  • Macro: Stabilization in the industrial environment would support demand for measurement technology and automation solutions

Analysis

From recommendation (March 9, 2026)

Fortive's strength lies in the nature of its products: They are business-critical but account for only a small proportion of customers' total costs - a combination that facilitates price increases and structurally limits customers' bargaining power. Large industrial customers and institutions have aligned their processes with Fortive solutions, which makes a change complex and expensive. This advantage is reflected in an operating margin of around 20% - even if the EBIT margin has come under slight pressure from 18.7% (2023) to 16.4% (2025), which should be kept in mind. The net margins show a similar trend: from 14.3% (2023) to 11.3% (2025) - not an alarm signal, but an indication that the cost structure has not yet been fully optimized following the restructuring. The analysts' consensus vote is currently Hold, which signals a balanced risk/reward profile - no euphoria, but also no skepticism about the business model. Anyone looking for defensive industrial exposure with real pricing power and a PEG below 1 will find a solidly positioned stock here - without the expectation of a short-term revaluation upwards.

Performance Figures of Fortive Corp

in USD

1M High / Low
64.33 / 59.30
52W High / Low
64.33 / 46.34
5Y High / Low
87.07 / 46.34
1M
+0.38%
3M
-0.67%
6M
+11.28%
1Y
+19.37%
3Y
+10.01%
5Y
+18.71%

Relative Performance vs Benchmarks

PeriodFortive Corp vs DAX vs S&P 500 (SPY)
1M +0.38% -0.36% -0.29%
3M -0.67% -3.96% -4.33%
6M +11.28% +11.19% +3.61%
1Y +19.37% +16.79% +1.73%
3Y +10.01% -43.73% -58.23%
5Y +18.71% -40.35% -60.82%

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Historical valuation trends

How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.

PeriodP/E RatioP/S RatioP/B RatioP/CF Ratio
Current34.94.03.117.6
1Y ago22.72.81.711.5
3Y ago24.93.32.615.4
5Y ago10.33.52.615.0

Frequently Asked Questions

From recommendation (March 9, 2026)

Is Fortive Corp a good investment?

Fortive Corp has a Leeway Score of 60.5/100, which is rated as Excellent. The Leeway Score combines business quality, fundamental evaluation, and valuation cycle into a comprehensive assessment. A higher score indicates stronger investment quality based on AI-powered fundamental analysis.

What does Fortive Corp do?

Fortive Corp is a company characterized by the following investment thesis: Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington. Fortive Corp operates in the Technology / Scientific & Technical Instruments industry is based in USA employs around 10,000 people. Fortive Corp recently reported revenue of about 4.24B USD, a profit margin of 12.84%, return on equity of 6.81%, a market capitalisation around 18.37B USD, valuation multiples of roughly 35.2x earnings, 4.3x sales, 3x book value. Analyst consensus currently expects earnings per share of around 3.22 USD with year‑over‑year growth of 7.60%. Fortive Corp has an ongoing dividend policy and pays around 0.20 USD per share (0.33% yield).

What are the key metrics for FTV.NYSE?

Key metrics for FTV.NYSE include valuation (P/E 31.6, P/S 3.6, P/B 2.8), profitability (profit margin 13.93%, ROE 6.40%), and growth (revenue 4.60%, earnings -2.60%). Market capitalization is 18.53B USD. These metrics give an overview of the company's financial performance and valuation.

How has Fortive Corp's stock price performed?

Fortive Corp's stock has returned — over 1 year, — over 3 years, and — over 5 years. Performance can vary depending on market conditions and company developments.

How is FTV.NYSE valued?

FTV.NYSE has the following valuation metrics: P/E Ratio: 31.6, P/S Ratio: 3.6, P/B Ratio: 2.8. These metrics help assess whether the stock is fairly valued compared to its fundamentals.

What are the growth catalysts for Fortive Corp?

The key growth catalysts for Fortive Corp are:
  • 17. March: CFO appearance on J.P. Morgan Industrials Conference - Guidance and capital allocation signals
  • Next quarterly results: Confirmation of margin path after Group reorganization
  • M&A-Updates: Fortive has recently completed acquisitions - further portfolio measures possible
  • Macro: Stabilization in the industrial environment would support demand for measurement technology and automation solutions
These factors can positively influence the company's future growth and performance.

What are the key risks when investing in FTV.NYSE?

Key risks for FTV.NYSE include: Fortive operates across test and measurement, industrial sensors and safety, connected worker and facilities software, and healthcare sterilization and clinical workflow. It faces competition from specialized instrumentation firms and larger industrial conglomerates, where the real battles are fought over product performance, software and services recurring revenue, and pricing power. The company carries three material constraints: supply chain and component cost swings that hit margins unpredictably, the weight of medical and data regulation in its healthcare division, and lingering post-spin financial, tax, and indemnity obligations that can tighten capital allocation and compress returns.
  • Intense competition across multiple segments—test and measurement, sensors, industrial software, and healthcare sterilization—creates persistent pressure on pricing, demands sustained R&D investment, and threatens market position.
  • Supply-chain and input-cost exposure—reliance on limited or sole sources for key components, swings in commodity and freight costs, and tariff or trade policy volatility that can disrupt production and compress margins.
  • Regulatory and product-compliance risk in healthcare and industrial safety stems from FDA/MDR/UKCA oversight, post-market reporting obligations, and privacy and anti-fraud frameworks (HIPAA, Anti-Kickback, False Claims Act). Violations can trigger recalls, regulatory fines, sales restrictions, and materially higher compliance costs. [8, 3, 21]
  • Post-separation financial risks include indemnities and contingent liabilities carried over from the Ralliant spin-off, tax exposures tied to the separation transaction itself, and leverage combined with interest-rate sensitivity that could constrain both liquidity and strategic flexibility.
Investors should consider these risk factors carefully before making an investment decision.

Who are the main competitors of Fortive Corp?

Fortive Corp competes with several listed peers in its sector. Fortive operates as a focused industrial-technology and healthcare-workflow company, split between Intelligent Operating Solutions and Advanced Healthcare Solutions. It competes against large diversified industrials and specialist vendors in diagnostics, instruments, industrial automation, and electronic instrumentation. The business faces familiar headwinds: cyclical industrial demand, competitors willing to spend aggressively on R&D and pricing, execution risk as the portfolio reshapes through M&A, and the ongoing regulatory and cybersecurity complexity that comes with healthcare and connected products.
  • Danaher Corporation (DHR.NYSE)
  • Emerson Electric Co. (EMR.NYSE)
  • AMETEK, Inc. (AME.NYSE)
These competitors influence pricing power, growth opportunities and relative valuation.

When does Fortive Corp report earnings?

Fortive Corp's next earnings report date is July 29, 2026.

Key Metrics

From recommendation (March 9, 2026)

Market Capitalization
18.53B USD
P/E Ratio
31.65
Analyst Target Price
62.19 USD

Valuation Metrics

P/S Ratio
3.56
P/B Ratio
2.84

Profitability Metrics

Profit Margin
13.93%
Operating Margin
20.13%
Return on Equity
6.40%
Return on Assets
3.13%

Growth Metrics

Revenue Growth
4.60%
Earnings Growth
-2.60%

Dividend history

Long-term record of paid dividends (amount per share and dividend yield at the time of payment).

YearDividendYield at paymentAvg. yield
20260.06 USD0.10%0.11%
20260.06 USD0.11%
20250.06 USD0.11%
20250.06 USD0.12%
20250.05 USD0.10%
20250.06 USD0.11%
20250.06 USD0.10%
20240.06 USD0.10%
20240.06 USD0.11%
20240.06 USD0.11%
20240.06 USD0.09%
20230.06 USD0.12%
20230.05 USD0.09%
20230.05 USD0.11%
20230.05 USD0.11%

Earnings history & estimates

Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.

Historical earnings performance

85%
Beat estimate
2.5%
Miss estimate
+6.07%
Avg surprise when beat
-1.69%
Avg surprise when miss

Reports analyzed: 40

Upcoming earnings report

July 29, 2026
Next earnings date · USD

Analyst estimates for upcoming periods

Next year
December 31, 2027
Consensus3.22
Range3.05 – 3.28
15 analysts
Est. growth vs prior: 7.6%
Revisions: 7d ↑0 ↓0 · 30d ↑1 ↓1
Next quarter
September 30, 2026
Consensus0.71
Range0.69 – 0.72
12 analysts
Est. growth vs prior: 3.83%
Revisions: 7d ↑1 ↓0 · 30d ↑1 ↓0

Key financial figures

All figures in USD

Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.

20252024202320222021
Revenue5.14B6.23B6.07B5.83B5.25B
Operating income (EBIT)908.90M1.12B1.13B971.80M831.50M
Net income579.20M832.90M865.80M755.20M608.40M
Free cash flow978.10M1.41B1.25B1.21B911.10M
Total assets11.74B17.02B16.91B15.89B16.47B
Equity6.45B10.19B10.32B9.68B9.51B
Net debt2.83B3.06B1.92B2.71B3.32B
© Leeway
PWP Leeway UG (haftungsbeschränkt)
Leeway Icon